Skip to main content

Table 3 Current and potential use of non-thiazides for hypertension

From: The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis

 

Current use of non-thiazides (DDDs/1000 inhabitants/day)*

Potential decrease (DDDs/1000 inhabitants/day)†

Canada

92.7

2.8 (3%)

France

98.9

17.2 (17%)

Germany

107.7

13.5 (13%)

Norway

92.7

20.3 (22%)

UK

70.8

15.4 (22%)

US

127.7

8.4 (7%)

  1. * Calculated from country-specific IMS-data for the year 2000. Combination drugs are not included † Corresponding to the potential increase in use of thiazides (table 2)